Citadel Advisors
WGS icon

Citadel Advisors’s GeneDx Holdings WGS Stock Holding History

Citadel Advisors’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.73M Sell
42,500
-29,000
-41% -$2.64M ﹤0.01% 5448
2025
Q4 		$9.3M Hold
71,500
– – ﹤0.01% 3351
2025
Q3 		$7.7M Sell
71,500
-8,200
-10% -$893K ﹤0.01% 3633
2025
Q2 		$7.36M Buy
79,700
+21,200
+36% +$1.66M ﹤0.01% 3477
2025
Q1 		$5.18M Buy
58,500
+9,200
+19% +$798K ﹤0.01% 3811
2024
Q4 		$3.79M Sell
49,300
-7,300
-13% -$510K ﹤0.01% 4428
2024
Q3 		$2.4M Buy
56,600
+9,800
+21% +$331K ﹤0.01% 5184
2024
Q2 		$1.22M Buy
46,800
+1,600
+4% +$30.3K ﹤0.01% 6205
2024
Q1 		$413K Buy
+45,200
New +$271K ﹤0.01% 8804
2023
Q4 		– Sell
-1,000
Closed -$3.64K – 15356
2023
Q3 		$3.64K Sell
1,000
-776
-44% -$4.25K ﹤0.01% 13564
2023
Q2 		$10.6K Buy
1,776
+424
+31% +$3.36K ﹤0.01% 13196
2023
Q1 		$16.3K Buy
1,352
+140
+12% +$1.87K ﹤0.01% 13213
2022
Q4 		$10.6K Buy
1,212
+779
+180% +$17.2K ﹤0.01% 13614
2022
Q3 		$13K Buy
+433
New +$19.8K ﹤0.01% 12209
2022
Q2 		– Sell
-394
Closed -$40K – 14228
2022
Q1 		$40K Sell
394
-721
-65% -$80.1K ﹤0.01% 12942
2021
Q4 		$164K Sell
1,115
-488
-30% -$109K ﹤0.01% 12150
2021
Q3 		$402K Sell
1,603
-1,227
-43% -$421K ﹤0.01% 10401
2021
Q2 		$1.31M Buy
2,830
+1,060
+60% +$455K ﹤0.01% 7652
2021
Q1 		$870K Buy
+1,770
New +$920K ﹤0.01% 8444

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Citadel Advisors's WGS Position: Q1 2026 in Review

Citadel Advisors increased its GeneDx Holdings (WGS) stake by 255% in Q1 2026, buying an estimated $42.4M and bringing the position to 647,401 shares worth $41.6M. The position accounts for 0.01% of the portfolio, ranked #1532.

Citadel Advisors first reported a position in WGS in Q1 2021 and has held it in 19 quarters since. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Citadel Advisors held 647,401 shares of GeneDx Holdings worth $41.6M as of Q1 2026.
  • Citadel Advisors bought 465,050 GeneDx Holdings shares in Q1 2026, an estimated $42.4M.
  • GeneDx Holdings made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1532 holding.
  • Citadel Advisors first reported a position in GeneDx Holdings in Q1 2021 and has held it in 19 quarters since.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.